Dr. Anna Pei-Hua Hsu, MD

Dr. Hsu practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Hsu's NPI, 1902023625, was assigned on April 20, 2007. Dr. Hsu graduated from David Geffen School of Medicine at UCLA in 2001. Dr. Hsu holds California license A80339.

Dr. Hsu's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Hsu's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Hsu to 2 more group practices and clinics, 1 physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsu practices, 4 sites in all. Vendor and product names are available with a free account.

Facial plastic surgery is Dr. Hsu's primary specialty in the NPI Registry, under taxonomy code 207YS0123X. Dr. Hsu is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Hsu is licensed in California.

Dmand AI lists chronic nasal allergies, ear eustachian tube disorders, hearing loss and impairment, swimmer's ear, tinnitus, upper respiratory infection (URI) and vertigo among the conditions Dr. Hsu treats.

CMS data shows 563 Medicare services from Dr. Hsu across 8 procedure codes in 2024, for 217 Medicare patients. Medicare paid $44,555 for them. Every service was in an office.

CMS counts 217 Medicare patients who saw Dr. Hsu in 2024. The largest group is 75 to 84, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hsu's median patient age at 65, with 60% women.

In 2024, Dr. Hsu wrote 206 Medicare Part D claims for 75 patients. 98% of them were for generic drugs. CMS names the drug for 129 of them, across 3 drugs with 11 or more claims each, at $1,977 in total drug cost. In 2023, CMS named 108 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hsu for performance year 2024, reported as part of a group. Dr. Hsu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 44 general payments to Dr. Hsu from 14 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $800.

Dr. Hsu graduated from David Geffen School of Medicine at UCLA in 2001.

Dr. Hsu is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.